Certified by Founder Lodge
Cytotheryx, Inc.
United States - Rochester, MN
START UP
1 Disclosed Funding Rounds $60,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cytotheryx is a platform technology company focused on the development of a high-quality, consistent source of primary human hepatocytes (PHH), the functional cells of the liver.
Based in
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 13 ,2026 | Series A | $60,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Slate Medicines | $130,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
